Halozyme Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence.
CEOHelen I. Torley
CEOHelen I. Torley
Employees350
Employees350
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1998
Founded1998
Employees350
Employees350
HALO Key Statistics
Market cap7.66B
Market cap7.66B
Price-Earnings ratio15.30
Price-Earnings ratio15.30
Dividend yield—
Dividend yield—
Average volume2.48M
Average volume2.48M
High today$66.92
High today$66.92
Low today$65.05
Low today$65.05
Open price$66.60
Open price$66.60
Volume1.49M
Volume1.49M
52 Week high$79.50
52 Week high$79.50
52 Week low$42.01
52 Week low$42.01
HALO News
TipRanks 22h
Halozyme Appoints New Chief Operating OfficerElevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
TipRanks 22h
Halozyme names Cortney Caudill as COOIn a regulatory filing, Halozyme (HALO) said, “On October 1, 2025, Cortney Caudill was appointed as Senior Vice President, Chief Operating Officer of Halozyme T...
Seeking Alpha 6d
Halozyme to acquire Elektrofi, a biopharma focused on drug deliveryHalozyme Therapeutics (NASDAQ:HALO) announced on Wednesday that it has agreed to acquire Elektrofi, Inc., a Boston-based company focused on drug delivery techno...
Analyst ratings
50%
of 10 ratingsBuy
50%
Hold
40%
Sell
10%
More HALO News
TipRanks 6d
Halozyme sees Elektrofi deal less than 5% dilutive to EPS over medium term“The transaction is expected to be less than 5% dilutive to Non-GAAP diluted EPS over medium-term, excluding potential milestone payments related to programs in...
People also own
Based on the portfolios of people who own HALO. This list is generated using Robinhood data, and it’s not a recommendation.